Simron Singh: (Webcast presented by the Press office of ASCO-GI)
0 Views
administrator
07/09/23
Simron Singh MD, MPH, FRCP(C). Efficacy and safety of everolimus in advanced, progressive, nonfunctional neuroendocrine tumors (NET) of the gastrointestinal (GI) tract and unknown primary: A subgroup analysis of the phase III RADIANT-4 trial.[nbsp]Abstract 315
Show more
Facebook Comments
No comments found